Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127356912 | 12735691 | 2 | F | 20160912 | 20160913 | 20160915 | EXP | NO-ALVOGEN-2016-ALVOGEN-028378 | ALVOGEN | 63.00 | YR | F | Y | 0.00000 | 20160915 | PH | NO | NO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127356912 | 12735691 | 1 | PS | ATENOLOL. | ATENOLOL | 1 | Y | 18240 | 50 | MG | QD | ||||||||
| 127356912 | 12735691 | 2 | SS | FELODIPINE. | FELODIPINE | 1 | U | 0 | 10 | MG | QD | ||||||||
| 127356912 | 12735691 | 3 | SS | ERY-MAX | ERYTHROMYCIN | 1 | Oral | Y | 0 | 500 | MG | TABLET | TID | ||||||
| 127356912 | 12735691 | 4 | SS | MICARDIS PLUS | HYDROCHLOROTHIAZIDETELMISARTAN | 1 | 12.5/80 MG | U | 0 | QD | |||||||||
| 127356912 | 12735691 | 5 | SS | ISOPHANE INSULIN | INSULIN NOS | 1 | 18 + 16 IU | U | 0 | ||||||||||
| 127356912 | 12735691 | 6 | SS | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | U | 0 | 1000 | MG | BID | ||||||||
| 127356912 | 12735691 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | U | 0 | 20 | MG | QD | ||||||||
| 127356912 | 12735691 | 8 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 | 2.5 | MG | |||||||||
| 127356912 | 12735691 | 9 | C | ALBYL-E | ASPIRINMAGNESIUM OXIDE | 1 | U | 0 | 75 | MG | QD | ||||||||
| 127356912 | 12735691 | 10 | C | NEURONTIN | GABAPENTIN | 1 | U | 0 | 600 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127356912 | 12735691 | 1 | Product used for unknown indication |
| 127356912 | 12735691 | 2 | Product used for unknown indication |
| 127356912 | 12735691 | 3 | Respiratory tract infection |
| 127356912 | 12735691 | 4 | Product used for unknown indication |
| 127356912 | 12735691 | 5 | Product used for unknown indication |
| 127356912 | 12735691 | 6 | Product used for unknown indication |
| 127356912 | 12735691 | 7 | Product used for unknown indication |
| 127356912 | 12735691 | 8 | Product used for unknown indication |
| 127356912 | 12735691 | 9 | Product used for unknown indication |
| 127356912 | 12735691 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127356912 | 12735691 | HO |
| 127356912 | 12735691 | LT |
| 127356912 | 12735691 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127356912 | 12735691 | Acute kidney injury | |
| 127356912 | 12735691 | Drug interaction | |
| 127356912 | 12735691 | Hyperkalaemia | |
| 127356912 | 12735691 | Hypoglycaemia | |
| 127356912 | 12735691 | Hypotension | |
| 127356912 | 12735691 | Hypothermia | |
| 127356912 | 12735691 | Lactic acidosis | |
| 127356912 | 12735691 | Sinus bradycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |